DS
WST icon

David Shaw’s West Pharmaceutical WST Stock Holding History

David Shaw’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,000
Closed -$3.02M – 5571
2022
Q2 		$3.02M Hold
10,000
– – ﹤0.01% 2700
2022
Q1 		$4.11M Sell
10,000
-15,400
-61% -$6.03M ﹤0.01% 2546
2021
Q4 		$11.9M Buy
25,400
+17,600
+226% +$7.58M 0.01% 1497
2021
Q3 		$3.31M Buy
+7,800
New +$3.29M ﹤0.01% 2527
2020
Q1 		– Sell
-11,700
Closed -$1.76M – 4313
2019
Q4 		$1.76M Sell
11,700
-10,000
-46% -$1.46M ﹤0.01% 2577
2019
Q3 		$3.08M Buy
21,700
+11,700
+117% +$1.61M ﹤0.01% 2037
2019
Q2 		$1.25M Buy
+10,000
New +$1.18M ﹤0.01% 2540

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

David Shaw's WST Position: Q2 2026 in Review

David Shaw reduced its West Pharmaceutical (WST) stake by 7.9% in Q2 2026, selling an estimated $340K and leaving 12,890 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

David Shaw first reported a position in WST in Q2 2013 and has held it in 37 quarters since. The position peaked at $140M in Q4 2024. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • David Shaw held 12,890 shares of West Pharmaceutical worth $4.63M as of Q2 2026.
  • David Shaw sold 1,111 West Pharmaceutical shares in Q2 2026, an estimated $340K.
  • West Pharmaceutical made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2472 holding.
  • David Shaw first reported a position in West Pharmaceutical in Q2 2013 and has held it in 37 quarters since.
  • David Shaw's West Pharmaceutical position peaked at $140M in Q4 2024.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.